Recent Findings in Lung Transplants Described by Researchers from Ohio State University College of Medicine (No survival benefit to gaining private…

Recent Findings in Lung Transplants Described by Researchers from Ohio State University College of Medicine (No survival benefit to gaining private health insurance coverage for post-lung transplant care in adults with cystic fibrosis)

By a News Reporter-Staff News Editor at Insurance Weekly News -- New research on Transplant Medicine - Lung Transplants is the subject of a report. According to news reporting out of Columbus, Ohio, by VerticalNews editors, research stated, "The use of public insurance is associated with diminished survival in patients with cystic fibrosis (CF) following lung transplantation. No data exist on benefits of gaining private health insurance for post-transplant care among such patients previously using public insurance."

Our news journalists obtained a quote from the research from the Ohio State University College of Medicine, "The United Network for Organ Sharing database was used to identify first-time lung transplant recipients participating in Medicare or Medicaid, diagnosed with CF, and transplanted between 2005 and 2015. Survival outcomes were compared between recipients gaining private insurance after transplantation and those maintaining public coverage throughout follow-up. Since implementation of the lung allocation score, 575 adults with CF received lung transplantation funded by Medicare or Medicaid and contributed data on insurance status post-transplant. There were 128 (22%) patients who gained private insurance. Multivariable analysis of time-varying insurance status found no survival benefit of gaining private insurance (HR=0.822; 95% CI=0.525, 1.286; p=0.390). Further analysis demonstrated that resuming public insurance coverage was detrimental, relative to gaining and keeping private insurance (HR=2.315; 95% CI=1.020, 5.258; p=0.045)."

According to the news editors, the research concluded: "Survival disadvantages of lung transplant recipients with CF who have public health insurance were not ameliorated by a switch to private coverage for post-transplant care."

For more information on this research see: No survival benefit to gaining private health insurance coverage for post-lung transplant care in adults with cystic fibrosis. Clinical Transplantation, 2016;30(3):320-7. (Wiley-Blackwell - www.wiley.com/; Clinical Transplantation - onlinelibrary.wiley.com/journal/10.1111/(ISSN)1399-0012)

Our news journalists report that additional information may be obtained by contacting D. Tumin, Pediatrics, The Ohio State University College of Medicine, Columbus, OH, United States. Additional authors for this research include R.E. Foraker, J.D. Tobias and D. Hayes.

Keywords for this news article include: Ohio, Biomedicine, Surgery, Columbus, Medicaid, Medicare, United States, Health Policy, Cystic Fibrosis, Health Insurance, Organ Transplants, Transplant Medicine, Lung Transplantation, North and Central America, Lung Diseases and Conditions, Pancreatic Diseases and Conditions, Digestive System Diseases and Conditions.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC